Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
The studies showed that survodutide therapy led to a maximum placebo-corrected body weight loss of 13.8% by week 16, demonstrating its potential for significant weight loss [110]
Made with patented liposome encapsulation technology for cell-level absorption that powers healthy collagen, immune system, and skin
Injectable GLP-1 RAs are not meal-dependent, while oral semaglutide must be taken on an empty stomach with a small amount of water
Structured monitoring and support are essential regardless of treatment approach
Out of stock Secure Payment Your payment is 100% protected with a secure encrypted checkout and trusted payment providers
US$ 28.88
US$ 23.63
US$ 26.96
US$ 23.05
